Articles
  

The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients with Atherosclerosis

Abstract

Atherosclerosis is a chronic inflammatory condition that affects the arterial wall. Oxidized low- density lipoprotein (ox-LDL) seems to have an important role in atherosclerotic plaque formation.
This study was performed to investigate the effects of ox-LDL as well as PHA on proliferation and gene expression of  peripheral blood  mononuclear  cells (PBMCs) in patients with atherosclerosis compared  to  healthy controls. Proliferation of  PBMCs was assessed by BrdU assay, while gene expression was assessed by real-time PCR.
Both PHA and ox-LDL significantly induced proliferation of PBMCs of patients and controls. PBMCs  from  controls  showed  significantly higher  proliferation  when  stimulated  with  ox-LDL compared to patients. Expression of TGF-β was significantly lower in PBMCs from patients compared to healthy controls (p<0.001). Following simulation with PHA, TGF-β and Foxp3 gene expression levels in patients and controls were significantly decreased (p<0.001). Expression of Foxp3 in PBMCs treated with ox-LDL was significantly decreased in patients and controls.
Decreased expression of TGF-β and Foxp3 genes after ox-LDL stimulation may be due to more sensitivity of Treg cells than effector T cells to ox-LDL. Presence of ox-LDL within atheroma could be associated with the diminished population of Treg cells in the atherosclerotic patients.

1. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol 2009; 31(1):23-33.
2. Mahmoudi M, Siassi F, Mahmoudi MJ, Eshraghian MR, Zarnani AH, Rezaei N, et al. Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease. Iran J Allergy Asthma Immunol 2010; 9(3):133-40.
3. Mahmoudi MJ, Hedayat M, Rezaei N, Saboor-Yaraghi AA, Mahmoudi M. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease. Iran J Allergy Asthma Immunol 2011; 8(4):237-42.
4. Fei GZ, Huang YH, Swedenborg J, Frostegard J.Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism. Atherosclerosis 2003; 169(1):77-85.
5. Caspar-Bauguil S, Saadawi M, Negre-Salvayre A, Thomsen M, Salvayre R, Benoist H. Mildly oxidized low- density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro. Biochem J 1998; 330 ( Pt 2):659-66.
6. Fortun A, Khalil A, Gagne D, Douziech N, Kuntz C, Jay- Gerin JP, et al. Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001; 156(1):11-21.
7. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64(1):5-15.
8. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585(2-3):213-21.
9. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, et al.Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF- beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181(4):2277-84.
10. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, et al.The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127(1):89-97.
11. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007;2(8):e779.
12. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12(2):178-80.
13. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16(5):518-24.
14. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27(4):893-900.
15. Mor A, Luboshits G, Planer D, Keren G, George J.Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006; 27(21):2530-7.
16. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12(4):461-7.
17. Mahmoudi MJ, Mahmoudi M, Siassi F, Shokri F, Eshraghian MR, Zarnani AH, et al. Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis. Iran J Immunol 2011; 8(1):27-33.
18. Lee KC, Wong M, Spitzer D. Chloroquine as a probe for antigen processing by accessory cells. Transplantation 1982; 34(3):150-3.
19. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC.Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104(7):746-9.
20. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S,Boersma E, Simoons ML, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107(16):2109-14.
21. Blasi C. The autoimmune origin of atherosclerosis.Atherosclerosis, 2008; 201(1):17-32.
22. Ni Choileain N, Redmond HP. Regulatory T-cells and autoimmunity. J Surg Res 2006; 130(1):124-35.
23. Randolph DA, Fathman CG. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med 2006;57:381-402.
24. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101(5):455-8.
25. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med 2007; 17(4):113-8.

Files
IssueVol 11, No 3 (2012) QRcode
SectionArticles
Keywords
Atherosclerosis Gene expression Ox-LDL Peripheral blood mononuclear cells T regulatory cells
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mottaghi A, Salehi E, Sezavar H, Keshavarz SA, Eshraghian MR, Rezaei N, Rejali L, Saboor-Yaraghi A-A. The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients with Atherosclerosis. Iran J Allergy Asthma Immunol. 1;11(3):217-223.